Health Care & Life Sciences » Pharmaceuticals | Allergan PLC

Allergan PLC

Allergan PLC
Stock Exchange Frankfurt Stock Exchange
EPS
 -
Market Cap
 -
Shares Outstanding
 392.44 M
Public Float
 -
Allergan PLC
Stock Exchange Mexican Stock Exchange
EPS
 MXN422.69
Market Cap
 MXN1.03 T
Shares Outstanding
 392.44 M
Public Float
 -
Allergan PLC
Stock Exchange New York Stock Exchange
EPS
 $21.58
Market Cap
 $54.97 B
Shares Outstanding
 327.82 M
Public Float
 331.68 M

Profile

Address
Clonshaugh Business & Tech. Park
Dublin Dublin D17 E400
Ireland
Employees -
Website http://www.allergan.com
Updated 07/08/2019
Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States.

Financials

View All
Created with Highcharts 5.0.14Allergan PLCNet Income. Fiscal year is January-December. All values USD Millions.7507501 6311 6312 9462 9469419413 7233 7235 0965 09620132014201520162017201801k2k3k4k5k6k
Created with Highcharts 5.0.14Allergan PLCSales/Revenue. Fiscal year is January-December. All values USD Millions.8 6788 67813 06213 06212 68812 68814 57114 57115 94115 94115 78715 78720132014201520162017201805k10k15k20k

Brenton L. Saunders
Chairman, President & Chief Executive Officer
Michael E. Greenberg
Director
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.